Managing the peritoneal surface component of gastrtointestinal cancer

ONCOLOGY

Volumn 18, Issue 1, 2004, Pages 51-59

  Sugarbaker, Paul H ^a  

^a WASHINGTON CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL SURGERY; ADJUVANT CHEMOTHERAPY; COLLOID CARCINOMA; GASTROINTESTINAL TUMOR; HUMAN; METHODOLOGY; PATHOLOGY; PERITONEAL CAVITY; PERITONEUM TUMOR; PROGNOSIS; QUALITY OF LIFE; REOPERATION; REVIEW; SURVIVAL RATE;

ADENOCARCINOMA, MUCINOUS; CHEMOTHERAPY, ADJUVANT; DIGESTIVE SYSTEM SURGICAL PROCEDURES; GASTROINTESTINAL NEOPLASMS; HUMANS; PERITONEAL CAVITY; PERITONEAL NEOPLASMS; PROGNOSIS; QUALITY OF LIFE; REOPERATION; SURVIVAL RATE;

EID: 2142758069     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Temple WJ (guest ed): Surgical techniques and outcomes. Surg Oncol Chn North Am 9(1), 2002.
2. Taylor I: What constitutes good practice in surgical oncology? Eur J Surg Oncol 27:517-520, 2001.
3. Sugarbaker PH: Peritonectomy procedures. Ann Surg 221:29-42, 1995.
4. Spratt JS, Adcock RA, Sherrill W, et al: Hyperthermia peritoneal perfusion system in canines. Cancer Res 40:253-255, 1980.
5. Speyer JL, Sugarbaker PH, Collins JM, et al: Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans. Cancer Res 4:1916-1922, 1981.
6. Koga S, Hamazoe R, Maeta M, et al: Treatment of implanted peritoneal cancer in rats by continuous hyperthermic peritoneal perfusion in combination with an anticancer drug. Cancer Res 44:1840-1842, 1984.
7. Flessner MF, Dedrick RL, Schultz JS: A distributable model of peritoneal plasma transport: Theoretical considerations. Am J Physiol 246:R597-607, 1984.
8. Sugarbaker PH, Gianola FJ, Speyer JL, et al: Prospective randomized trial of intravenous v peritoneal 5-FU in patients with advanced primary colon or rectal cancer. Semin Oncol 12(3 suppl 4):101-111, 1985.
9. Koga S, Hamazoe R, Maeta M, et al: Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C. Cancer 61:232-237, 1988.
10. Fujimoto S, Shrestha RD, Kokubun M, et al: Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding. Ann Surg 208:36-41, 1988.
11. Sugarbaker PH, Jablonski KA: Prognostic features of 51 colorectal and 130 appendicial cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 221:124-132, 1995.
12. Yonemura Y, Fujimura T, Nishimura G, et al: Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery 119:437-444, 1996.
13. Yu W, Whang I, Suh I, et al: Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer. Ann Surg 228:347-354, 1998.
14. Moran BJ, Cecil TD: The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surg Oncol Clin N Am 12:585-603, 2003.
15. Urano M, Kuroda M, Nishimura Y: For the clinical application of thermo-chemotherapy given at mild temperatures. Int J Hyperthermia 15:79-107, 1999.
16. Verwaal VJ, van Ruth S, de Bree E, et al: Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy vs systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21:3737-3743, 2003.
17. Gertsch P: A historical perspective on colorectal liver metastases and peritoneal carcinomatosis: Similar results, different treatments. Surg Oncol Clin N Am 12:531-541, 2003.
18. Sugarbaker PH, Graves T, DeBruijn EA, et al: Rationale for early postoperative intraperitoneal chemotherapy (EPIC) in patients with advanced gastrointestinal cancer. Cancer Res 50:5790-5794, 1990.
19. Jacquet P, Averbach A, Stephens AD, et al: Heated intraoperative intrapentoneal mitomycin C and early postoperative intraperitoneal 5-fluorouracil: Pharmacokinetic studies. Oncology 55:130-138, 1998.
20. Chu DZ, Lang NP, Thompson C, et al: Peritoneal carcinomatosis in non-gynecologic malignancy. A prospective study of prognostic factors. Cancer 63:364-367, 1989.
21. Sadeghi B, Arvieux C, Glehen O, et al: Peritoneal carcinomatosis from non-gynecologic malignancies. Results of the EVOCAPE 1 multicentric prospective study. Cancer 88:358-363, 2000.
22. Jayne DG, Fook S, Loi C, et al: Peritoneal carcinomatosis from colorectal cancer. Br J Surg 89:1454-1550, 2002.
23. Jones T: I want to live!, in Erdrich L, Kenison K, (eds): The Best American Short Stories 1993, pp 127-145. New York, Houghton Mifflin Company, 1993.
24. Sampson JA: Implantation peritoneal carcinomatosis of ovarian origin. Am J Pathol VII: 423-443, 1931.
25. Weiss L: Metastatic inefficiency: Causes and consequences. Cancer Metastasis Rev 3: 1-24, 1986.
26. Kodera Y, Yamamura Y, Shimizu Y, et al: Peritoneal washing cytology: Prognostic value of positive findings in patients with gastric carcinoma undergoing a potentially curative resection. J Surg Oncol 72:60-65, 1999.
27. Zoetmulder FAN: Modelstudies Over Het Colorectale Carcinoom. Amsterdam, Rodopi, 1982.
28. Autio V: The spread of intraperitoneal infection. Studies with Roentgen contrast medium. Acta Chir Scand 321(suppl):5-31, 1964.
29. Meyers MA: Distribution of intra-abdominal malignant seeding: Dependency on dynamics of flow of ascitic fluid. Am J Roentgenol Radium Ther Nucl Med 119:198-206, 1973.
30. Shimotsuma M, Shields JW, Simpson-Morgan MW, et al: Morpho-physiological functiona and role of omental milky spots as omentum associated lymphoid tissue (OALT) in the peritoneal cavity. Lymphology 26:90-101, 1993.
31. Sugarbaker PH: Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology, in Sugarbaker PH (ed): Peritoneal Carcinomatosis: Principles of Management, pp 79-100. Boston, Kluwer, 1996.
32. Carmignani CP, Sugarbaker T, Bromley CM, et al: Intraperitoneal cancer dissemination: Mechanisms of the patterns of spread. Cancer Metastasis Rev 22:465-472, 2003.
33. Sugarbaker PH, Kern K, Lack E: Malignant pseudomyxoma of colonic origin. Natural history and presentation of a curative approach to treatment. Dis Colon Rectum 30:772-779, 1987.
34. Sugarbaker PH: Review of a personal experience in the management of carcinomatosis and sarcomatosis. Jpn J Clin Oncol 31:573-583, 2001.
35. Link KH, Roitman M, Holtappels, et al: Intraperitoneal chemotherapy with mitoxantrone in malignant ascites. Surg Oncol Clin N Am 12:865-872, 2003.
36. Sugarbaker PH: The subpyloric space: An important surgical and radiologic feature in pseudomyxoma peritonei. Eur J Surg Oncol 28:443-446, 2002.